Clinical Research Directory
Browse clinical research sites, groups, and studies.
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Sponsor: IHU Strasbourg
Summary
EGO-Trial is the first multicenter study in France which aims to evaluate the efficacy of Endoscopic Sleeve Gastroplasty (ESG) in patients with obesity. This project fills a critical national gap by providing real-world, multicentric data from diverse French healthcare settings, offering insight into the safety, efficacy, and variability of ESG practices across institutions The project is expected to generate robust, multicentric clinical evidence on the safety and efficacy of ESG in patients with obesity within the French healthcare context.
Official title: Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2026-03
Completion Date
2030-03
Last Updated
2026-03-04
Healthy Volunteers
No
Conditions
Interventions
Endoscopic sleeve gastroplasty
Endoscopic sleeve gastroplasty is performed using a CE marked endoscopic suture device which allows for a reduction in stomach volume without resection or anastomosis
Locations (10)
Hôpital Privé de Provence
Aix-en-Provence, France
Polyclinique de Franche-Comté
Besançon, France
Clnique des Cèdres
Échirolles, France
Hôpital HURIEZ
Lille, France
Hospices Civils de Lyon - Hôpital Edourard HERRIOT
Lyon, France
Clinique Clémentville
Montpellier, France
Centre Mutualiste de l'Obésité
Saint-Etienne, France
Polyclinique Sainte Thérèse
Sète, France
Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil
Strasbourg, France
Clinique les Eaux Claires
Baie-Mahault, Guadeloupe